Show Screener



ILMN $326.47

6.66 (2.1%)


ILMN Profile

MEMBERSHIP
Nasdaq 100 S&P 500
SECTOR
Health Care
MARKET CAPITALIZATION

$47 Billion

Large-Cap
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (about 70% of sales). Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (12% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 18% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.

ILMN Earnings

EPS

1.59

P/E

57.38

Q2 Earnings for Apr, May & Jun

Mon, Jul 29, 2019

Since Earnings Report

ILMN +8.5%

Q3 Earnings for Jul, Aug & Sep

Thu, Oct 24, 2019

Since Earnings Report

ILMN +4.4%

ILMN Dividend

Dividend Yield

0.00%

Dividend Rate

$0.00

Ex-Dividend Date

--

Dividend Pay Date

--

Dividend Frequency

--

Dividend Payments

--

ILMN Charts

All Time High $380.76 Wed, Jul 10, 2019


ILMN Industry Competitors


MEDICAL EQUIPMENT & DEVICES
Abbott Laboratories
Medtronic
Thermo Fisher Scientific
Danaher
Stryker
Becton Dickinson
Intuitive Surgical
Boston Scientific
Edwards Lifesciences
Baxter International



Symbol MC DY Price Day YTD
ILMN $47.01 0.00% $326.47 2.1% 10.9%
















Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com



    TOP    

©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy Terms Of Service Privacy Policy